HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Membrane studies on rod-shaped red cells in hereditary elliptocytosis: least haemolysis and normal sodium influx with decreased membrane lipids.

Abstract
The clinical features of hereditary elliptocytosis were studied in 25 cases and compared with 20 normal individuals. Based on morphological features, these patients were classified into two groups: those with a rod-shaped type of elliptocytosis (nine cases), and those with a non-rod type (16 cases). Most of the cases with overt haemolysis were detected among cases of the non-rod type. Overt haemolysis typically tended to be accompanied by stomatocytic changes, which appear to be superimposed on elliptic transformation of the red cells. Sodium influx increased in eight of nine HE patients with overt haemolysis, but in none of the HE with rod-shaped red cells. Significant quantitative and qualitative differences in red cell membrane lipids were observed between the two types of HE. No spectrin abnormalities in domain composition, dimer-dimer association, and thermal stability were observed in 11 of the HE patients studied, including four cases with overt haemolysis.
AuthorsA Kanzaki, A Ikeda, Y Yawata
JournalBritish journal of haematology (Br J Haematol) Vol. 70 Issue 1 Pg. 105-12 (Sep 1988) ISSN: 0007-1048 [Print] England
PMID3179218 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Membrane Lipids
  • Spectrin
  • Sodium
Topics
  • Adult
  • Elliptocytosis, Hereditary (blood, metabolism)
  • Erythrocyte Count
  • Erythrocyte Membrane (metabolism)
  • Erythrocytes, Abnormal (classification, ultrastructure)
  • Hemolysis
  • Humans
  • Membrane Lipids (metabolism)
  • Microscopy, Electron, Scanning
  • Sodium (pharmacokinetics)
  • Spectrin (analysis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: